Validated in the US and proven globally
Across multiple studies and care settings in Australia, New Zealand, the UK, and Canada, PainChek® has consistently delivered measurable clinical outcomes:
- Medication optimization: Reduced use of analgesics, antipsychotics, antidepressants, anxiolytics, and hypnotics
- Resident well-being: Improved nutrition, increased mobility, reduced dependency, and improved quality of life
- Safety and care quality: Fewer falls, reduced distress, and improved staff confidence in pain assessment
- Operational benefits: Improved care efficiency and significant cost savings
In a pivotal clinical trial in the US, PainChek® demonstrated strong agreement with the internationally recognized Abbey Pain Scale, delivering accurate pain intensity assessments and reliable performance across diverse resident demographics and device platforms.
